FINNENCE ▪ THE WIRE FILE
THE WIRE · № 78908
Price move▼ Bearish
SPDR Biotech ETF -3.0%
KINDPrice move
DIRECTION▼ Bearish
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Small-cap biotech underperformance signals risk-off in speculative healthcare names.
Small-cap biotech leads healthcare lower
CATALYST TO WATCH
Rate expectations or M&A headlines
MAIN RISK
Sharp snapback on deal news
FULL DISPATCH
SPDR Biotech ETF (XBI) moved -3.0% in the latest period (1d). Close: 146.80, prior: 151.40.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares XBI, Healthcare
Syndax Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Syndax (SNDX)2026-10-14 02:17 UTC
Syndax Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Syndax (SNDX)2026-10-14 02:17 UTC
←CORRELATIONshares Healthcare
Johnson & Johnson CFO Joseph Wolk: 'You can't heap enough praise on the pharma unit'2026-10-13 16:30 UTC
Johnson & Johnson CFO Joseph Wolk: 'You can't heap enough praise on the pharma unit'2026-10-13 16:30 UTC
←CORRELATIONshares Healthcare
What private practices, hospitals and investors should know about the M&A market in cardiology2026-10-13 19:48 UTC
What private practices, hospitals and investors should know about the M&A market in cardiology2026-10-13 19:48 UTC
←CORRELATIONshares Healthcare
Sensor Patch Market to Reach US$ 28.9 Bn by 2031, Growing at 29.6% CAGR as Continuous Glucose and Cardiac Monitoring Expand: Wissen Research2026-10-13 20:34 UTC
Sensor Patch Market to Reach US$ 28.9 Bn by 2031, Growing at 29.6% CAGR as Continuous Glucose and Cardiac Monitoring Expand: Wissen Research2026-10-13 20:34 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.